Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma.

导出 OA

翻译打印收藏纠错

作者： Shingo,Inaguma ^[1] ; Zengfeng,Wang ^[2] ; Jerzy,Lasota ^[1] ; Masanori,Onda ^[1] ; Piotr,Czapiewski ^[3] ; Renata,Langfort ^[4] ; Janusz,Rys ^[5] ; Joanna,Szpor ^[6] ; Piotr,Waloszczyk ^[7] ; Krzysztof,Okoń ^[8] ; Wojciech,Biernat ^[9] ; Hiroshi,Ikeda ^[8] ; David S,Schrump ^[4] ; Raffit,Hassan ^[2] ; Ira,Pastan ^[10] ; Markku,Miettinen ^[10]

作者单位： Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA. ^[1] Department of Pathology, Aichi Medical University School of Medicine, Nagakute, Japan. ^[2] Laboratory of Molecular Biology, National Cancer Institute, Bethesda, MD, USA. ^[3] Department of Pathomorphology, Medical University of Gdansk, Gdansk, Poland. ^[4] Department of Pathology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany. ^[5] Department of Pathology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland. ^[6] Department of Tumor Pathology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Krakow Branch, Poland. ^[7] Department of Pathomorphology, Jagiellonian University, Krakow, Poland. ^[8] Independent Laboratory of Pathology, Zdunomed, Szczecin, Poland. ^[9] Thoracic and GI Oncology Branch, National Cancer Institute, Bethesda, MD, USA. ^[10]

关键词 5B2 MN-1 immunohistochemistry malignant pleural mesothelioma mesothelin (MSLN)